Evidence for altered cholesterol metabolism in H untington's disease post mortem brain tissue

Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · see citing works

Neuropathological Classification of Huntingtonʼs Disease

Vonsattel, J., Myers, R. H., STEVENS, T. J., Ferrante, R. J., Bird, E. D., & Richardson, E. P. (1985) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-198511000-00003 · Cited by 2,598 · see citing works

CNS synaptogenesis promoted by glia-derived cholesterol

Mauch, D. H., Nägler, K., Schumacher, S., Göritz, C., Müller, E.-C., Otto, A., & Pfrieger, F. W. (2001) · Science · doi:10.1126/science.294.5545.1354 · Cited by 1,711 · see citing works

Cholesterol and the cell membrane

Yèagle, P. L. (1985) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(85)90011-5 · Cited by 1,492 · see citing works

Untitled work

Binder (2004) · doi:10.1080/08977190410001723308 · Cited by 1,481 · see citing works

Loss of Huntingtin-Mediated BDNF Gene Transcription in Huntington's Disease

Zuccato, C., Ciammola, A., Rigamonti, D., Leavitt, B. R., Goffredo, D., Conti, L., MacDonald, M. E., Friedlander, R. M., Silani, V., Hayden, M. R., et al. (2001) · Science · doi:10.1126/science.1059581 · Cited by 1,319 · see citing works

Huntington Disease

Vonsattel, J. P., & DiFiglia, M. (1998) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199805000-00001 · Cited by 1,305 · see citing works

Brain-derived neurotrophic factor in neurodegenerative diseases

Zuccato, C., & Cattaneo, E. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.54 · Cited by 947 · see citing works

Alzheimer's disease: the cholesterol connection

Puglielli, L., Tanzi, R. E., & Kovacs, D. M. (2003) · Nature Neuroscience · doi:10.1038/nn0403-345 · Cited by 864 · see citing works

Evidence of Increased Oxidative Damage in Both Sporadic and Familial Amyotrophic Lateral Sclerosis

Ferrante, R. J., Browne, S. E., Shinobu, L. A., Bowling, A. C., Baik, M. J., MacGarvey, U. M., Kowall, N. W., Brown, R. H., & Beal, M. F. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69052064.x · Cited by 808 · see citing works

cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain

Lund, E. G., Guileyardo, J. M., & Russell, D. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7238 · Cited by 668 · see citing works

Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation

Björkhem, I., Lütjohann, D., Diczfalusy, U., Ståhle, L., Ahlborg, G., & Wahren, J. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32188-x · Cited by 538 · see citing works

Oxidative stress in Huntington’s disease

Browne, S. E., Ferrante, R. J., & Beal, M. F. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00216.x · Cited by 508 · see citing works

Evidence for more widespread cerebral pathology in early HD

Rosas, H. D., Koroshetz, W. J., Chen, Y. I., Skeuse, C., Vangel, M. G., Cudkowicz, M., Caplan, K., MAREK, K. L., Seidman, L. J., Makris, N., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000065888.88988.6e · Cited by 499 · see citing works

Autopsy Samples of Alzheimer's Cortex Show Increased Peroxidation In Vitro

Subbarao, K. V., Richardson, J. S., & Ang, L. C. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb08858.x · Cited by 463 · see citing works

Morphometric Demonstration of Atrophic Changes in the Cerebral Cortex, White Matter, and Neostriatum in Huntington's Disease

de la Monte, S. M., Vonsattel, J., & Richardson, E. P. (1988) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-198809000-00003 · Cited by 434 · see citing works

Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain

Björkhem, I. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01725.x · Cited by 381 · see citing works

Mutations in the 3β-Hydroxysterol Δ24-Reductase Gene Cause Desmosterolosis, an Autosomal Recessive Disorder of Cholesterol Biosynthesis

Waterham, H. R., Koster, J., Romeijn, G. J., Hennekam, R. C. M., Vreken, P., Andersson, H. C., FitzPatrick, D. R., Kelley, R. I., & Wanders, R. J. A. (2001) · The American Journal of Human Genetics · doi:10.1086/323473 · Cited by 355 · see citing works

Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease

Heverin, M., Bogdanović, N., Lütjohann, D., Bayer, T. A., Pikuleva, I. A., Brétillon, L., Diczfalusy, U., Winblad, B. G., & Björkhem, I. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300320-jlr200 · Cited by 325 · see citing works

Critical Role for Cholesterol in Lyn-mediated Tyrosine Phosphorylation of FcεRI and Their Association with Detergent-resistant Membranes

Sheets, E. D., Holowka, D., & Baird, B. A. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.145.4.877 · Cited by 320 · see citing works

Oxidative Damage in Huntington's Disease Pathogenesis

Browne, S. E., & Beal, M. F. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.2061 · Cited by 309 · see citing works

Outsourcing in the brain: Do neurons depend on cholesterol delivery by astrocytes?

Pfrieger, F. W. (2003) · BioEssays · doi:10.1002/bies.10195 · Cited by 308 · see citing works

Marked differences in cholesterol synthesis between neurons and glial cells from postnatal rats

Nieweg, K., Schaller, H., & Pfrieger, F. W. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05917.x · Cited by 307 · see citing works

Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans.

Kempen, H. J. M., Glatz, J. F. C., Leuven, J. A. G., van der Voort, H. A., & Katan, M. (1988) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38456-x · Cited by 304 · see citing works

Dysfunction of the Cholesterol Biosynthetic Pathway in Huntington's Disease

Valenza, M., Rigamonti, D., Goffredo, D., Zuccato, C., Fenu, S., Jamot, L., Strand, A., Tarditi, A., Woodman, B., Racchi, M., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3355-05.2005 · Cited by 298 · see citing works

Differential Expression of Cholesterol Hydroxylases in Alzheimer's Disease

Brown, J. A., Theisler, C. M., Silberman, S., Magnuson, D. J., Gottardi-Littell, N. R., Lee, J. M., Yager, D., Crowley, J., Sambamurti, K., Rahman, M. M., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402324200 · Cited by 268 · see citing works

Engagement of GPI-Linked CD48 Contributes to TCR Signals and Cytoskeletal Reorganization

Moran, M., & Miceli, M. C. (1998) · Immunity · doi:10.1016/s1074-7613(00)80644-5 · Cited by 267 · see citing works

Crossing the barrier: net flux of 27-hydroxycholesterol into the human brain

Heverin, M., Meaney, S., Lütjohann, D., Diczfalusy, U., Wahren, J., & Björkhem, I. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500024-jlr200 · Cited by 263 · see citing works

Lipid rafts and little caves

Zajchowski, L. D., & Robbins, S. M. (2002) · European Journal of Biochemistry · doi:10.1046/j.0014-2956.2001.02715.x · Cited by 247 · see citing works

Decreased Neuronal and Increased Oligodendroglial Densities in Huntington's Disease Caudate Nucleus

Myers, R. H., Vonsattel, J. P., Paskevich, P. A., Kiely, D. K., Stevens, T. J., Cupples, L. A., Richardson, E. P., & Bird, E. D. (1991) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199111000-00005 · Cited by 239 · see citing works

Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications

Bartzokis, G., Lu, P. H., Tishler, T. A., Fong, S. M., Oluwadara, B., Finn, J. P., Huang, D., Bordelon, Y., Mintz, J., & Perlman, S. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9352-7 · Cited by 238 · see citing works

Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses

Sipione, S., Rigamonti, D., Valenza, M., Zuccato, C., Conti, L., Pritchard, J., Kooperberg, C. L., Olson, J. M., & Cattaneo, E. F. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu539 · Cited by 222 · see citing works

On the turnover of brain cholesterol in patients with Alzheimer's disease. Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells

Bogdanović, N., Brétillon, L., Lund, E. G., Diczfalusy, U., Lannfelt, L., Winblad, B. G., Russell, D. W., & Björkhem, I. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02277-7 · Cited by 213 · see citing works

Role of Lipoproteins in the Delivery of Lipids to Axons during Axonal Regeneration

de Chaves, E. I. P., Rusiñol, A. E., Vance, D. E., Campenot, R. B., & Vance, J. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.30766 · Cited by 209 · see citing works

Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses

Sipione, S. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.17.1953 · Cited by 209 · see citing works

Increased Brain β-Amyloid Load, Phosphorylated Tau, and Risk of Alzheimer Disease Associated With an Intronic CYP46 Polymorphism

Papassotiropoulos, A., Streffer, J. R., Tsolaki, M., Schmid, S., Thal, D. R., Nicosia, F. M., Iakovidou, V., Maddalena, A. S., Lütjohann, D., Ghebremedhin, E., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.1.29 · Cited by 208 · see citing works

Morphometric analysis of the prefrontal cortex in Huntington's disease

Sotrel, A., Paskevich, P. A., Kiely, D. K., Bird, E. D., Williams, R. S., & Myers, R. H. (1991) · Neurology · doi:10.1212/wnl.41.7.1117 · Cited by 204 · see citing works

Glial Lipoproteins Stimulate Axon Growth of Central Nervous System Neurons in Compartmented Cultures

Hayashi, H., Campenot, R. B., Vance, D. E., & Vance, J. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313828200 · Cited by 191 · see citing works

Lipid Pathway Alterations in Parkinson's Disease Primary Visual Cortex

Cheng, D., Jenner, A. M., Shui, G., Cheong, W. F., Mitchell, T. W., Nealon, J. R., Kim, W. S., McCann, H., Wenk, M. R., Halliday, G. M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017299 · Cited by 189 · see citing works

Cholesterol Defect Is Marked across Multiple Rodent Models of Huntington's Disease and Is Manifest in Astrocytes

Valenza, M., Leoni, V., Karasinska, J. M., Petricca, L., Fan, J., Carroll, J., Pouladi, M. A., Fossale, E., Nguyen, H. P., Riess, O., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0917-10.2010 · Cited by 166 · see citing works

Huntington's disease – neuropathology

Vonsattel, J. P., Keller, C. E., & Cortes, E. P. (2011) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52014-2.00004-5 · Cited by 159 · see citing works

Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson's disease

Abbott, S. K., Li, H., Muñoz, S. S., Knoch, B., Batterham, M. J., Murphy, K. E., Halliday, G. M., & Garner, B. (2013) · Movement Disorders · doi:10.1002/mds.25729 · Cited by 154 · see citing works

Oxysterols and Alzheimer's disease

Björkhem, I., Heverin, M., Leoni, V., Meaney, S., & Diczfalusy, U. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00684.x · Cited by 154 · see citing works

Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's disease

Leoni, V., Mariotti, C., Tabrizi, S. J., Valenza, M., Wild, E. J., Henley, S. M. D., Hobbs, N. Z., Mandelli, M. L., Grisoli, M., Björkhem, I., et al. (2008) · Brain · doi:10.1093/brain/awn212 · Cited by 146 · see citing works

Novel route for elimination of brain oxysterols across the blood-brain barrier: conversion into 7α-hydroxy-3-oxo-4-cholestenoic acid

Meaney, S., Heverin, M., Panzenboeck, U., Ekström, L., Axelsson, M., Andersson, U., Diczfalusy, U., Pikuleva, I. A., Wahren, J., Sattler, W., et al. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m600529-jlr200 · Cited by 144 · see citing works

Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease

Kölsch, H., Lütjohann, D., Ludwig, M. Z., Schulte, A., Ptok, U., Jessen, F., von Bergmann, K., Rao, M. L., Maier, W., & Heun, R. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001109 · Cited by 139 · see citing works

Cholesterol homeostasis failure as a unifying cause of synaptic degeneration

Koudinov, A. R., & Koudinova, N. V. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.11.036 · Cited by 139 · see citing works

Striatal oxidative damage parallels the expression of a neurological phenotype in mice transgenic for the mutation of Huntington’s disease

Pérez‐Severiano, F., Rı́os, C., & Segovia, J. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02082-5 · Cited by 135 · see citing works

Cholesterol‐dependent modulation of dendrite outgrowth and microtubule stability in cultured neurons

Fan, Q., Yu, W., Gong, J., Zou, K., Sawamura, N., Senda, T., Yanagisawa, K., & Michikawa, M. (2001) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00686.x · Cited by 134 · see citing works

Measurement of oxysterols and α-tocopherol in plasma and tissue samples as indices of oxidant stress status

Iuliano, L., Micheletta, F., Natoli, S., Ginanni Corradini, S., Iappelli, M., Elisei, W., Giovannelli, L., Violi, F., & Diczfalusy, U. (2003) · Analytical Biochemistry · doi:10.1016/s0003-2697(02)00467-0 · Cited by 134 · see citing works

Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation

Valenza, M., Carroll, J. B., Leoni, V., Bertram, L., Björkhem, I., Singaraja, R. R., Donato, S. D., Lütjohann, D., Hayden, M. R., & Cattaneo, E. F. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm170 · Cited by 129 · see citing works

Progressive dysfunction of the cholesterol biosynthesis pathway in the R6/2 mouse model of Huntington’s disease

Valenza, M., Leoni, V., Tarditi, A., Mariotti, C., Björkhem, I., Donato, S. D., & Cattaneo, E. F. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.07.004 · Cited by 123 · see citing works

Marked accumulation of 27-hydroxycholesterol in SPG5 patients with hereditary spastic paresis

Schüle, R., Siddique, T., Deng, H., Yang, Y., Donkervoort, S. C., Hansson, M. E. A., Madrid, R. E., Siddique, N., Schöls, L. J., & Björkhem, I. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m002543 · Cited by 118 · see citing works

Plasma 24S-hydroxycholesterol correlation with markers of Huntington disease progression

Leoni, V., Long, J. D., Mills, J. A., Donato, S. D., & Paulsen, J. S. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.03.013 · Cited by 102 · see citing works

Marked accumulation of 27-hydroxycholesterol in the brains of Alzheimer's patients with the Swedish APP 670/671 mutation

Shafaati, M., Marutle, A., Pettersson, H. I., Lövgren‐Sandblom, A., Olin, M., Pikuleva, I. A., Winblad, B. G., Nordberg, A. K., & Björkhem, I. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m014548 · Cited by 102 · see citing works

Altered cholesterol homeostasis contributes to enhanced excitotoxicity in Huntington’s disease

del Toro, D., Xifró, X., Pol, A., Humbert, S., Saudou, F., Canals, J. M., & Alberch, J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06912.x · Cited by 100 · see citing works

Zinc supplementation inhibits lipid peroxidation and the development of atherosclerosis in rabbits fed a high cholesterol diet.

Jenner, A., Ren, M., Rajendran, R., Ning, P., Huat, B. T. K., Watt, F., & Halliwell, B. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.11.024 · Cited by 96 · see citing works

Polyglutamine expansion in huntingtin alters its interaction with phospholipids

Kegel, K. B., Sapp, E., Alexander, J. S., Valencia, A., Reeves, P., Li, X., Masso, N., Sobin, L. B., D, N. A. M., & DiFiglia, M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06255.x · Cited by 94 · see citing works

An Improved High‐Throughput Lipid Extraction Method for the Analysis of Human Brain Lipids

Abbott, S. K., Jenner, A. M., Mitchell, T. W., Brown, S. H. J., Halliday, G. M., & Garner, B. (2013) · Lipids · doi:10.1007/s11745-013-3760-z · Cited by 88 · see citing works

Increased expression of cholesterol 24S‐hydroxylase results in disruption of glial glutamate transporter EAAT2 association with lipid rafts: a potential role in Alzheimer’s disease

Tian, G., Kong, Q., Lai, L., Ray‐Chaudhury, A., & Lin, C. G. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06661.x · Cited by 87 · see citing works

Levels of 7-oxocholesterol in cerebrospinal fluid are more than one thousand times lower than reported in multiple sclerosis

Leoni, V., Lütjohann, D., & Masterman, T. (2004) · Journal of Lipid Research · doi:10.1194/jlr.c400005-jlr200 · Cited by 83 · see citing works

Free Cholesterol Alters Lipid Raft Structure and Function Regulating Neutrophil Ca2+ Entry and Respiratory Burst: Correlations with Calcium Channel Raft Trafficking

Kannan, K. B., Barlos, D., & Hauser, C. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.5253 · Cited by 69 · see citing works

Protein misfolding inside cells: The case of huntingtin and Huntington's disease

Hatters, D. M. (2008) · IUBMB Life · doi:10.1002/iub.111 · Cited by 69 · see citing works

Up‐regulation of β‐amyloidogenesis in neuron‐like human cells by both 24‐ and 27‐hydroxycholesterol: protective effect of N‐acetyl‐cysteine

Gamba, P., Guglielmotto, M., Testa, G., Monteleone, D., Zerbinati, C., Gargiulo, S., Biasi, F., Iuliano, L., Giaccone, G., Mauro, A., et al. (2014) · Aging Cell · doi:10.1111/acel.12206 · Cited by 63 · see citing works

Deuterium uptake and plasma cholesterol precursor levels correspond as methods for measurement of endogenous cholesterol synthesis in hypercholesterolemic women

Matthan, N. R., Raeini−Sarjaz, M., Lichtenstein, A. H., Ausman, L. M., & Jones, P. J. H. (2000) · Lipids · doi:10.1007/s11745-000-0616-9 · Cited by 55 · see citing works

Association of cholesterol oxidation and abnormalities in fatty acid metabolism in cystic fibrosis

Iuliano, L., Monticolo, R., Straface, G., Zullo, S., Galli, F., Boaz, M., & Quattrucci, S. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27757 · Cited by 49 · see citing works

Photodamage Generates 7‐keto‐ and 7‐hydroxycholesterol in the Rat Retina via a Free Radical‐mediated Mechanism

Rodríguez, I. R., & Fliesler, S. J. (2009) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2009.00568.x · Cited by 42 · see citing works

Multifaceted roles of BDNF and FGF2 in human striatal primordium development. An in vitro study

Sarchielli, E., Marini, M., Ambrosini, S., Peri, A., Mazzanti, B., Pinzani, P., Barletta, E., Ballerini, L., Paternostro, F., Paganini, M., et al. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.04.021 · Cited by 26 · see citing works

Dissociation of ERK signalling inhibition from the anti-amyloidogenic action of synthetic ceramide analogues

Li, H., Evin, G. M., Hill, A. F., Hung, Y. H., Bush, A. I., & Garner, B. (2011) · Clinical Science · doi:10.1042/cs20110257 · Cited by 8 · see citing works

Ergothioneine, recent developments

Cheah, I. K.-M., & Halliwell, B. B. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101868 · Cited by 200 · see citing works

Cholesterol oxidation products and their biological importance

Kulig, W., Cwiklik, L., Jurkiewicz, P., Róg, T., & Vattulainen, I. (2016) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2016.03.001 · Cited by 182 · see citing works

Lipid Oxidation Derived Aldehydes and Oxysterols Between Health and Disease

Sottero, B., Leonarduzzi, G., Testa, G., Gargiulo, S., Poli, G., & Biasi, F. (2018) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.201700047 · Cited by 137 · see citing works

CYP46A1 gene therapy deciphers the role of brain cholesterol metabolism in Huntington’s disease

Kacher, R., Lamazière, A., Heck, N., Kappès, V., Mounier, C., Després, G., Dembitskaya, Y., Perrin, E., Christaller, W., Nair, S. S., et al. (2019) · Brain · doi:10.1093/brain/awz174 · Cited by 115 · see citing works

Lipids as biomarkers of brain disorders

Hussain, G., Anwar, H., Rasul, A., Imran, A., Qasim, M., Zafar, S., Imran, M., Kamran, S., Aziz, N., Razzaq, A., et al. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1529653 · Cited by 105 · see citing works

Cholesterol 24-Hydroxylation by CYP46A1: Benefits of Modulation for Brain Diseases

Petrov, A. M., & Pikuleva, I. A. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00731-6 · Cited by 101 · see citing works

Altered Cholesterol Homeostasis in Huntington’s Disease

Kacher, R., Mounier, C., Caboche, J., & Bétuing, S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.797220 · Cited by 72 · see citing works

Cholesterol 24-hydroxylase: Brain cholesterol metabolism and beyond

Moutinho, M., Nunes, M. J., & Rodrigues, E. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.09.011 · Cited by 72 · see citing works

The role of cholesterol oxidation products in food toxicity

Maldonado‐Pereira, L., Schweiss, M. D., Barnaba, C., & Medina‐Meza, I. G. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.05.059 · Cited by 58 · see citing works

Biotin attenuation of oxidative stress, mitochondrial dysfunction, lipid metabolism alteration and 7β-hydroxycholesterol-induced cell death in 158N murine oligodendrocytes

Sghaier, R., Zarrouk, A., Nury, T., Badreddine, I., O’Brien, N. M., Mackrill, J. J., Véjux, A., Samadi, M. H., Nasser, B., Caccia, C., et al. (2019) · Free Radical Research · doi:10.1080/10715762.2019.1612891 · Cited by 55 · see citing works

Cell-intrinsic glial pathology is conserved across human and murine models of Huntington’s disease

Benraiss, A., Mariani, J. N., Osipovitch, M., Cornwell, A. B., Windrem, M. S., Villanueva, C. B., Chandler-Militello, D., & Goldman, S. A. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109308 · Cited by 54 · see citing works

Lipid metabolism in microglia: Emerging mechanisms and therapeutic opportunities for neurodegenerative diseases (Review)

Sun, Y., Wei, K., Liao, X., Wang, J., Gao, L., & Pang, B. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5580 · Cited by 57 · see citing works

Linking phytosterols and oxyphytosterols from food to brain health: origins, effects, and underlying mechanisms

Jie, F., Yang, X., Wu, L., Wang, M., & Lu, B. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1867819 · Cited by 50 · see citing works

Cholesteryl ester levels are elevated in the caudate and putamen of Huntington’s disease patients

Phillips, G. R., Hancock, S. E., Brown, S. H. J., Jenner, A. M., Kreilaus, F., Newell, K. A., & Mitchell, T. W. (2020) · Scientific Reports · doi:10.1038/s41598-020-76973-8 · Cited by 49 · see citing works

The translational potential of cholesterol-based therapies for neurological disease

Valenza, M., Birolini, G., & Cattaneo, E. F. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00864-5 · Cited by 48 · see citing works

Multi-omic analysis of Huntington’s disease reveals a compensatory astrocyte state

Paryani, F., Kwon, J., Ng, C., Jakubiak, K. A., Madden, N., Ofori, K., Tang, A., Lü, H., Xia, S., Li, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50626-0 · Cited by 49 · see citing works

Assessment of cholesterol homeostasis in the living human brain

Haider, A., Zhao, C., Wang, L., Xiao, Z., Rong, J., Xia, X., Chen, Z., Pfister, S. K., Mast, N., Yutuc, E., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.adc9967 · Cited by 44 · see citing works

Structure of Membrane-Bound Huntingtin Exon 1 Reveals Membrane Interaction and Aggregation Mechanisms

Tao, M., PANDEY, N. K., Barnes, R., Han, S., & Langen, R. (2019) · Structure · doi:10.1016/j.str.2019.08.003 · Cited by 42 · see citing works

Dysregulated Brain Cholesterol Metabolism Is Linked to Neuroinflammation in Huntington's Disease

González‐Guevara, E., Cárdenas, G., Pérez‐Severiano, F., & Martínez‐Lazcano, J. C. (2020) · Movement Disorders · doi:10.1002/mds.28089 · Cited by 43 · see citing works

Microtubule-associated protein 1 light chain 3B, (LC3B) is necessary to maintain lipid-mediated homeostasis in the retinal pigment epithelium

Dhingra, A., Bell, B. A., Peachey, N. S., Daniele, L. L., Reyes-Reveles, J., Sharp, R. C., Jun, B., Bazan, N. G., Sparrow, J. R., Kim, H. J., et al. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00351 · Cited by 41 · see citing works

Dietary cholesterol oxidation products: Perspectives linking food processing and storage with health implications

Liu, Y., Yang, X., Xiao, F., Jie, F., Zhang, Q., Liu, Y., Xiao, H., & Lu, B. (2021) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12880 · Cited by 40 · see citing works

Omics analysis of oxysterols to better understand their pathophysiological role

Sottero, B., Rossin, D., Staurenghi, E., Gamba, P., Poli, G., & Testa, G. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.05.026 · Cited by 38 · see citing works

Therapeutic Effects of Anthocyanins and Environmental Enrichment in R6/1 Huntington’s Disease Mice

Kreilaus, F., Spiro, A. S., Hannan, A. J., Garner, B., & Jenner, A. M. (2016) · Journal of Huntington s Disease · doi:10.3233/jhd-160204 · Cited by 38 · see citing works

Dimethyl fumarate and monomethyl fumarate attenuate oxidative stress and mitochondrial alterations leading to oxiapoptophagy in 158N murine oligodendrocytes treated with 7β-hydroxycholesterol

Sghaier, R., Nury, T., Leoni, V., Caccia, C., de Barros, J.-P. P., Cherif, A., Véjux, A., Moreau, T., Limem, K., Samadi, M. H., et al. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105432 · Cited by 36 · see citing works

Metabolic dysregulation in Huntington's disease: Neuronal and glial perspectives

Chang, C., Wu, C.-W., & Chern, Y. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106672 · Cited by 35 · see citing works

Metabolic Abnormalities in Patients with Chronic Disorders of Consciousness

Yu, J. Z., Meng, F., He, F., Chen, F., Bao, W., Yu, Y., Zhou, J., Gao, J., Li, J., Yao, Y., et al. (2021) · Aging and Disease · doi:10.14336/ad.2020.0812 · Cited by 34 · see citing works

The long and the short of Huntington’s disease: how the sphingolipid profile is shifted in the caudate of advanced clinical cases

Phillips, G. R., Saville, J. T., Hancock, S. E., Brown, S. H. J., Jenner, A. M., McLean, C., Fuller, M., Newell, K. A., & Mitchell, T. W. (2021) · Brain Communications · doi:10.1093/braincomms/fcab303 · Cited by 34 · see citing works

Influential role of 7-Ketocholesterol in the progression of Alzheimer’s disease

Mahalakshmi, K., Parimalanandhini, D., Sangeetha, R., Livya Catherene, M., Beulaja, M., Thiagarajan, R., Arumugam, M., Janarthanan, S., & Manikandan, R. (2021) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2021.106582 · Cited by 32 · see citing works

Towards a comprehensive understanding of the contributions of mitochondrial dysfunction and oxidative stress in the pathogenesis and pathophysiology of Huntington's disease

Tobore, T. O. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24492 · Cited by 32 · see citing works

Insights into White Matter Defect in Huntington’s Disease

Sun, Y., Tong, H., Yang, T., Liu, L., Li, X., & Li, S. (2022) · Cells · doi:10.3390/cells11213381 · Cited by 30 · see citing works

Cholesterol Metabolism in Neurodegenerative Diseases

He, K., Zhao, Z., Zhang, J., Li, D.-F., Wang, S., & Liu, Q. (2024) · Antioxidants and Redox Signaling · doi:10.1089/ars.2024.0674 · Cited by 24 · see citing works

Brain Cytochrome P450: Navigating Neurological Health and Metabolic Regulation

Durairaj, P., & Liu, Z. L. (2025) · Journal of Xenobiotics · doi:10.3390/jox15020044 · Cited by 28 · see citing works

Evidence of K+ homeostasis disruption in cellular dysfunction triggered by 7-ketocholesterol, 24S-hydroxycholesterol, and tetracosanoic acid (C24:0) in 158N murine oligodendrocytes

Bezine, M., Debbabi, M., Nury, T., Khalifa, R. B., Samadi, M. H., Cherkaoui‐Malki, M., Véjux, A., Raas, Q., Seze, J. D., Moreau, T., et al. (2017) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2017.03.006 · Cited by 26 · see citing works

The Potential Therapeutic Application of Simvastatin for Brain Complications and Mechanisms of Action

Vuu, Y. M., Shahib, A. K., & Rastegar, M. (2023) · Pharmaceuticals · doi:10.3390/ph16070914 · Cited by 29 · see citing works

The potential of CYP46A1 as a novel therapeutic target for neurological disorders: An updated review of mechanisms

Alavi, M. S., Karimi, G., Ghanimi, H. A., & Roohbakhsh, A. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175726 · Cited by 25 · see citing works

PolyQ length-dependent metabolic alterations and DNA damage drive human astrocyte dysfunction in Huntington’s disease

Lange, J., Gillham, O., Flower, M. D., Ging, H., Eaton, S. D., Kapadia, S., Neueder, A., Duchen, M. R., Ferretti, P., & Tabrizi, S. J. (2023) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2023.102448 · Cited by 23 · see citing works

CYP46A1 protects against NMDA-mediated excitotoxicity in Huntington's disease: Analysis of lipid raft content

Boussicault, L., Kacher, R., Lamazière, A., Vanhoutte, P., Caboche, J., Bétuing, S., & Potier, M. (2018) · Biochimie · doi:10.1016/j.biochi.2018.07.019 · Cited by 23 · see citing works

Role of membrane cholesterol and lipid peroxidation in regulating the Na + /K + -ATPase activity in schizophrenia

Dasgupta, A., Roy, S., Banerjee, U., Chowdhury, P., Mukhopadhyay, A., Saha, G., & Singh, O. P. (2016) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.192023 · Cited by 21 · see citing works

Targeting cytochrome P450 46A1 and brain cholesterol 24-hydroxylation to treat neurodegenerative diseases

Pikuleva, I. A. (2021) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2021.00013 · Cited by 19 · see citing works

Modulation of Kv3.1b potassium channel level and intracellular potassium concentration in 158N murine oligodendrocytes and BV-2 murine microglial cells treated with 7-ketocholesterol, 24S-hydroxycholesterol or tetracosanoic acid (C24:0)

Bezine, M., Maatoug, S., Khalifa, R. B., Debbabi, M., Zarrouk, A., Wang, Y., Griffiths, W. J., Nury, T., Samadi, M. H., Véjux, A., et al. (2018) · Biochimie · doi:10.1016/j.biochi.2018.02.008 · Cited by 19 · see citing works

Effect of Cholesterol on the Structure of Networked Water at the Surface of a Model Lipid Membrane.

Oh, M., Oh, C. I., & Weaver, D. (2020) · Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.0c01889 · Cited by 12 · see citing works

Implication of Oxysterols and Phytosterols in Aging and Human Diseases

Vigne, S., & Pot, C. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-43883-7_12 · Cited by 15 · see citing works

Pharmacological characterization of SAGE‐718, a novel positive allosteric modulator of N‐methyl‐ d ‐aspartate receptors

Beckley, J. T., Aman, T. K., Ackley, M. A., Kazdoba, T. M., Lewis, M., Smith, A. C., Farley, B. J., Dai, J., Deats, W., Hoffmann, E. C., et al. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16235 · Cited by 14 · see citing works

Dalzanemdor (SAGE‐718), a novel, investigational N‐methyl‐D‐aspartate receptor positive allosteric modulator: Safety, tolerability, and clinical pharmacology in randomized dose‐finding studies in healthy participants and an open‐label study in participants with Huntington's disease

Koenig, A. M., Lewis, M., Wald, J., Li, S., Varoglu, M., Dai, J., Sankoh, A. J., Paumier, K., Doherty, J., & Quirk, M. (2024) · Clinical and Translational Science · doi:10.1111/cts.13852 · Cited by 13 · see citing works

Mapping the oxidative stress metabolome in neurology by gas chromatography–mass spectrometry: a systematic review on signature-driven diagnosis and disease monitoring

Lorca, C., Serra, A., & Gallart‐Palau, X. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103925 · Cited by 12 · see citing works

Changes in 24(S)-Hydroxycholesterol Are Associated with Cognitive Performance in Early Huntington’s Disease: Data from the TRACK and ENROLL HD Cohorts

Gray, S. M., Dai, J., Smith, A. C., Beckley, J. T., Rahmati, N., Lewis, M., & Quirk, M. C. (2024) · Journal of Huntington s Disease · doi:10.3233/jhd-240030 · Cited by 12 · see citing works

Oxidative Stress in Huntington’s Disease

Jiménez‐Jiménez, F. J., Alonso‐Navarro, H., García‐Martín, E., Cárcamo-Fonfría, A., Caballero-Muñoz, M. D. M., & Agúndez, J. A. G. (2025) · Biomolecules · doi:10.3390/biom15040527 · Cited by 12 · see citing works

Polymeric nanotherapeutics: An emerging therapeutic approach for the management of neurodegenerative disorders

Chakraborty, P., Bhattacharyya, C., Sahu, R., Dua, T. K., Kandimalla, R. J. L., & Dewanjee, S. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.105267 · Cited by 11 · see citing works

Artemisinin Ameliorates the Neurotoxic Effect of 3-Nitropropionic Acid: A Possible Involvement of the ERK/BDNF/Nrf2/HO-1 Signaling Pathway

Arthur, R., Navik, U., & Kumar, P. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04487-9 · Cited by 11 · see citing works

A review of the putative antiseizure and antiepileptogenic mechanisms of action for soticlestat

Kondo, S., Murthy, V., Asgharnejad, M., Benitez, A., Nakashima, K., Hawkins, N. A., & White, H. S. (2025) · Epilepsia · doi:10.1111/epi.18287 · Cited by 11 · see citing works

Site of Cholesterol Oxidation Impacts Its Localization and Domain Formation in the Neuronal Plasma Membrane

Wilson, K. A., Wang, L., & O’Mara, M. L. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00395 · Cited by 11 · see citing works

Phospholipid Profiles Are Selectively Altered in the Putamen and White Frontal Cortex of Huntington’s Disease

Phillips, G. R., Hancock, S. E., Jenner, A. M., McLean, C., Newell, K. A., & Mitchell, T. W. (2022) · Nutrients · doi:10.3390/nu14102086 · Cited by 11 · see citing works

The Role of White Matter Dysfunction and Leukoencephalopathy/Leukodystrophy Genes in the Aetiology of Frontotemporal Dementias: Implications for Novel Approaches to Therapeutics

Lok, H. C., & Kwok, J. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052541 · Cited by 10 · see citing works

Dysregulated astrocyte cholesterol synthesis in Huntington's disease: A potential intersection with other cellular dysfunctions

Valenza, M. (2025) · Journal of Huntington s Disease · doi:10.1177/18796397251336192 · Cited by 9 · see citing works

Lipid-lowering drug targets and Parkinson's disease: A sex-specific Mendelian randomization study

Zhao, Y., & Taliun, S. A. G. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.940118 · Cited by 9 · see citing works

Optimization of mass spectrometry settings for steroidomic analysis in young and old killifish

Dabrowski, R., Ripa, R., Latza, C., Annibal, A., & Antebi, A. (2020) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-020-02640-6 · Cited by 9 · see citing works

Nigella and Milk Thistle Seed Oils: Potential Cytoprotective Effects against 7β-Hydroxycholesterol-Induced Toxicity on SH-SY5Y Cells

Hammouda, S., Ghzaiel, I., Picón-Pagès, P., Meddeb, W., Khamlaoui, W., Hammami, S. O., Muñoz, F. J., Hammami, M., & Zarrouk, A. (2021) · Biomolecules · doi:10.3390/biom11060797 · Cited by 8 · see citing works

Striatal Cholesterol Precursors Are Altered with Age in Female Huntington’s Disease Model Mice

Pfalzer, A. C., Wages, P. A., Porter, N. A., & Bowman, A. B. (2019) · Journal of Huntington s Disease · doi:10.3233/jhd-180321 · Cited by 8 · see citing works

The role of astrocytes in human Huntington's disease pathology

Al‐Dalahmah, O., & Goldman, J. E. (2025) · Journal of Huntington s Disease · doi:10.1177/18796397251344173 · Cited by 6 · see citing works

The Reversible Carnitine Palmitoyltransferase 1 Inhibitor (Teglicar) Ameliorates the Neurodegenerative Phenotype in a Drosophila Huntington’s Disease Model by Acting on the Expression of Carnitine-Related Genes

Bertapelle, C., Carillo, M. R., Cacciola, N. A., Shidlovskii, Y. V., Peluso, G., & Digilio, F. A. (2022) · Molecules · doi:10.3390/molecules27103125 · Cited by 6 · see citing works

A cutting-edge approach based on UHPLC-MS to simultaneously investigate oxysterols and cholesterol precursors in biological samples: Validation in Huntington's disease mouse model

Passoni, A., Favagrossa, M., Valenza, M., Birolini, G., Lanno, A., Mariotti, C., Cattaneo, E. F., Salmona, M., Colombo, L., & Bagnati, R. (2023) · Talanta Open · doi:10.1016/j.talo.2023.100278 · Cited by 5 · see citing works

A short-lived fish with long-lasting effects: hallmarks of aging in Nothobranchius furzeri

Savel, O., Lehmann, J., Poyraz, Y. K., & Page, M. M. (2026) · Frontiers in Aging · doi:10.3389/fragi.2025.1741819 · Cited by 6 · see citing works

Decreased SREBP2 of the striatal cell relates to disrupted protein degradation in Huntington’s disease

Cho, K., & Kim, G. W. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149250 · Cited by 5 · see citing works

The Diagnostic Use of the Plasma Quantification of 24S-Hydroxycholesterol and Other Oxysterols in Neurodegenerative Disease

Tripodi, D., Vitarelli, F., Spiti, S., & Leoni, V. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-43883-7_17 · Cited by 4 · see citing works

Neurotoxicity induced by lipid metabolism–associated endogenous toxicants

Mahalakshmi, K., Duraisamy, P., Sangeetha, R., Martin, L. C., Manikandan, B., & Manikandan, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23763-8.00079-8 · Cited by 4 · see citing works

Astrocyte-neuron combined targeting for CYP46A1 gene therapy in Huntington’s disease

Parsai, L.-H., Chali, F., Subashi, E., Zeitouny, C., Rey, E., Berniard, A., Bitton, W., Urli, L., Rousselot, L., Sarrazin, N., et al. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02054-4 · Cited by 4 · see citing works

Multi-OMIC analysis of Huntington disease reveals a neuroprotective astrocyte statePreprint

Paryani, F., Kwon, J., Ng, C. W., Madden, N., Ofori, K., Tang, A., Lü, H., Li, J., Mahajan, A., Davidson, S. M., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.08.556867 · Cited by 4 · see citing works

Viral vectors in neurodegenerative diseases: immune responses and therapeutic applications

Wang, Y., Mu, S., & Liu, F. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1603125 · Cited by 3 · see citing works

Role of Oxysterols in Ocular Degeneration Mechanisms and Involvement of P2X7 Receptor

Olivier, E., & Rat, P. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-43883-7_14 · Cited by 3 · see citing works

Navigating the cholesterol maze: Key insights on use of statins in neurodegenerative disorders

Kuan, J. H., Raghavan, R., Koh, D. L. W., Tan, W. Y., Iezhitsa, I. N., & Agarwal, R. (2026) · Neuroprotection/Neuroprotection (Chichester, England. Print) · doi:10.1002/nep3.70026 · Cited by 2 · see citing works

Lipid Messengers: Mechanisms and Clinical Applications of Exosomal Lipids in Neurodegenerative Diseases

Zhao, Y., Pan, M., He, S., & Zhou, X. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05794-z · Cited by 2 · see citing works

Cholestane-3β,5α,6β-triol Induces Multiple Cell Death in A549 Cells via ER Stress and Autophagy Activation

Chen, J., Zhang, J., Cai, L., Li, G., Cai, Z., Han, H., & Zhang, W. (2024) · Marine Drugs · doi:10.3390/md22040174 · Cited by 2 · see citing works

Oligodendrocytes in Huntington's Disease: A Review of Oligodendrocyte Pathology and Current Cell Reprogramming Approaches for Oligodendrocyte Modelling of Huntington's Disease

Back, A. M., Connor, B. J., & McCaughey‐Chapman, A. (2024) · Journal of Neuroscience Research · doi:10.1002/jnr.70010 · Cited by 2 · see citing works

Single nuclei RNAseq analysis of HD mouse models and human brain reveals impaired oligodendrocyte maturation and potential role for thiamine metabolismPreprint

Lim, R. G., Al‐Dalahmah, O., Wu, J., Gold, M. P., Reidling, J. C., Tang, G., Adam, M., Dansu, D. K., Park, H.-J., Casaccia, P., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.27.497613 · Cited by 2 · see citing works

Intravenous MSC-Treatment Improves Impaired Brain Functions in the R6/2 Mouse Model of Huntington’s Disease via Recovered Hepatic Pathological Changes

Yu-Taeger, L., El-Ayoubi, A., Qi, P., Danielyan, L., & Nguyen, H. P. (2024) · Cells · doi:10.3390/cells13060469 · Cited by 1 · see citing works

Concomitant pathologies and their impact on Huntington’s disease. A brief review of current evidence

Jellinger, K. A. (2025) · Journal of Neural Transmission · doi:10.1007/s00702-025-02957-5 · Cited by 1 · see citing works

Cholesterol and related sterols differentially modulate lipid domain dynamics in model membranes: A dual-probe analysis of domain-specific effects

Ayala‐Sanmartín, J., & Lamazière, A. (2025) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2025.105550 · Cited by 1 · see citing works

DHCR24 in cholesterol metabolism and diseases of the nervous system

Zhu, H. G., Li, S., Yang, Y. Z., 张似青, Wang, Y., & Xiong, T. (2026) · Lipids in Health and Disease · doi:10.1186/s12944-026-02954-x · Cited by 1 · see citing works

Caractérisation des activités cytoprotectrices de molécules utilisées dans le traitement de la sclérose en plaques (diméthyle fumarate, monométhyle fumarate, biotine) sur des oligodendrocytes 158N : impact sur le stress oxydant, le statut mitochondrial, le statut lipidique, l’apoptose et l’autophagie

Sghaier, R. (2019) · theses.fr (ABES) · doi:10.70675/5d9752b6zd8dcz4044z9137zad307bac6dbd · Cited by 1 · see citing works

Implication du canal potassium Kv3.1 dans la lipotoxicité du 7-cétocholestérol, 24S-hydroxycholestérol et de l’acide tétracosanoïque sur des cellules nerveuses 158N et BV-2 : Etude des relations entre Kv3.1, homéostasie potassique et métabolisme peroxysomal dans la maladie d’Alzheimer

Bezine, M. (2017) · theses.fr (ABES) · doi:10.70675/a634c389z7b07z4830zb56dzbf7b53a56944 · Cited by 1 · see citing works

Oxysterols in Human Brain

Jenner, A. M. (2017) · Springer eBooks · doi:10.1007/978-94-007-7864-1_168-1

Lipid metabolism in neurodegenerative diseases

Bogie, J. F. J., Guns, J., & Vanherle, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95582-9.00008-5

Sterol Biomarker Discovery In Neurodegenerative Diseases

Pacciarini, M. (2023) · doi:10.23889/suthesis.65375

Oxisteróis e sua relação com a neuroinflamação na esclerose lateral amiotrófica

Lima, R. S. (2023) · doi:10.11606/d.46.2023.tde-12122023-105206

Stress-associated neurodegenerative disorders: A mechanistic exploration

Venkatappa, M. M., Hanumegowda, S. M., Achur, R. N., & Sannaningaiah, D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95735-9.00025-5

The cholesterol 24-hydroxylase enzyme, CYP46A1, reduces overexpressed alpha-synuclein proteins in human cellular models of Parkinson’s disease.Preprint

Besnard‐Guérin, C., Rousselot, L., Audouard, E., Chali, F., & Piguet, F. (2024) · Research Square · doi:10.21203/rs.3.rs-4580957/v1

Oxysterol Alterations in SOD1G93A ALS Rats: 25-Hydroxycholesterol and LPS-Binding Protein in Disease ProgressionPreprint

Lima, R. S., Santos, R. S., Chaves‐Filho, A. B., Trzan, I. F. L., Inague, A., de Faria, R. L., Dantas, L. S., Pinto, I. F. D., de Medeiros, M. H. G., Steiner, A. A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.05.650333

Role of the cholesterol hydroxylase enzyme CYP46A1 in cholesterol metabolism and neuroprotection in Huntington's disease

Kacher, R. (2019) · theses.fr (ABES) · doi:10.70675/2e6ac10bz0700z4936z81f8z18565a62aaf5

Rôle des altérations transcriptionnelles et épigénétiques dans les déficits comportementaux de la maladie de Huntington

Lotz, C. (2019) · theses.fr (ABES) · doi:10.70675/35213e27zda27z484az886azd1ed4013e75a

Disruption of dopamine transmission by cholesterol depletion is associated with alterations in protein lipid raft partitioning and actin dynamics

Neel, A. I., Lee, E. T., West, A. M., Dawes, M. H., Schlitzer, R. D., Suddaby, R. A., Marrs, G. S., Jones, S. R., & Chen, R. (2026) · Neuropharmacology · doi:10.1016/j.neuropharm.2026.111078

Altered myelin sphingolipid and glycerophospholipid profiles in Huntington disease

Friedrich, M. G., Phillips, G. R., Young, R. S. E., Cameron, S., Bale, L. K., Michael, J. A., Su, H., Anastacio, H. T. D., McLean, C. A., Reid, G. E., et al. (2026) · Journal of Huntington s Disease · doi:10.1177/18796397261472539

Lipid dysregulation in polyglutamine diseases

Ni, L., Veeranki, V., Huang, B., & Lim, J. (2026) · Molecules and Cells · doi:10.1016/j.mocell.2026.100406

The human-specific lncRNA HD-LINC drives lipid droplet-associated neurodegeneration in Huntington’s diseasePreprint

Kwon, J., Wang, L., Ganti, N. R., Li, J., Xia, S., Al‐Dalahmah, O., & Yoo, A. S. J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.23.761349

Alteration of cholesterol homeostasis in the Huntington's disease brain

Kreilaus, F. (2015) · Research Online (University of Wollongong)

Whole body cholesterol metabolism is impaired in Huntington's disease

Leoni, V., Mariotti, C., Nanetti, L., Salvatore, E., Squitieri, F., Bentivoglio, A. R., del Poggio, M. B., Piacentini, S., Monza, D., Valenza, M., et al. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.03.025 · Cited by 90 · see citing works

Brain Cholesterol Synthesis and Metabolism is Progressively Disturbed in the R6/1 Mouse Model of Huntington’s Disease: A Targeted GC-MS/MS Sterol Analysis

Kreilaus, F., Spiro, A. S., Hannan, A. J., Garner, B., & Jenner, A. M. (2015) · Journal of Huntington s Disease · doi:10.3233/jhd-150170 · Cited by 26 · see citing works

Study of cholesterol metabolism in Huntington′s disease

Leoni, V., & Caccia, C. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.01.188 · Cited by 31 · see citing works

Cholesterol metabolism in Huntington disease

Karasinska, J. M., & Hayden, M. R. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.132 · Cited by 154 · see citing works